Development of a novel immune infiltration-based gene signature to predict prognosis and immunotherapy response of a novel anti-PD-L1/TGF-β bifunctional fusion protein in recurrent cervical cancer

The hypothesis-generating case study aimed at identifying those who are sensitive to anti-PD-L1 and TGF-β bifunctional fusion proteins and exploring potential mechanisms in the treatment of recurrent cervical cancer. We report that recurrent cervical cancer treated with anti-PD-L1 and TGF-β bifuncti...

Description complète

Détails bibliographiques

Auteurs principaux:	Yucen Mao, Naidong Xing, Wenxiong Sun, Xinyue Bao, Xihan Liu, Richao Wu, Jin Peng
Format:	Artigo
Langue:	Inglês
Publié:	Taylor & Francis Group 2026-12-01
Collection:	Human Vaccines & Immunotherapeutics
Sujets:	Recurrent cervical cancer anti-PD-L1/TGF-βRII bifunctional fusion protein tumor immunotherapy
Accès en ligne:	https://www.tandfonline.com/doi/10.1080/21645515.2026.2647560
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!